Jane Street Group, LLC Cytek Biosciences, Inc. Transaction History
Jane Street Group, LLC
- $445 Billion
- Q3 2024
A detailed history of Jane Street Group, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 136,402 shares of CTKB stock, worth $893,433. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,402
Previous 192,316
29.07%
Holding current value
$893,433
Previous $1.07 Million
29.64%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTKB
# of Institutions
134Shares Held
71.7MCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$77.1 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD9.49MShares$62.2 Million1.15% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$43.6 Million0.85% of portfolio
-
State Street Corp Boston, MA4.17MShares$27.3 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $882M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...